James Burt

Sales & Marketing

James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.